drugset / Trial / NCT01984268
ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
RandomizedParallel-groupSingle-blindTreatment
Summary
Adenocorticotrophic Hormone provides safe and effective treatment to induce disease remission in rheumatoid arthritis patients with active disease due to an inadequate response to methotrexate.
Timeline
- Start
- 2014-06-23
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acthar | Peptide | — | — |